FOS and cardiac hypertrophy: This alleviation was also observed by Kim-Mitsuyama et al., who demonstrated, through using a dominant negative mutant form of c-Jun to block AP-1 transcription factor binding to angiotensin II, the prevention of cardiac hypertrophy [37].